Quality of life of patients undergoing hymenoptera venom immunotherapy
Keywords
quality of life, immunotherapy, patientAbstract
Hymenoptera stings are one of the main causes of anaphylaxis in Europe [1] . Clinical observation shows that the most dangerous effects are those that develop immediately after the sting[2] . Most often, allergic symptoms occur within 5 to 20 minutes. There are reactions starting after 2 hours and sometimes even after 72 hours. The group of patients at risk of more severe reactions are atopic patients, patients with skin mastocytosis , the elderly, burdened with additional diseases. The highest mortality rate is observed in people over 50 years of age [3] . Aim : The aim of this study is to evaluate and compare parameters of quality of life, anxiety and anxiety among patients who have undergone immunotherapy for Hymenoptera venoms. Material and Methods : The research was conducted at the turn of January and February 2019. The study involved 100 patients desensitized to hymenoptera venoms in the Department of Allergology and Lung Diseases of the Provincial Specialist Hospital named after of Stefan Cardinal Wyszyński in Lublin. The diagnostic method that was used in the study was the diagnostic survey. The research tool used was the questionnaire: The World Health Organization Quality Of Life (WHOQOL) -BREF (short version of the questionnaire assessing the quality of life) extended by the author's questionnaire. The database was created and statistical analyzes were carried out based on Statistica 9.1 computer software. ( StatSoft, Poland). Rezults : The vast majority of respondents said that their quality of life is good or very good. As much as 82% gave such an answer. Only seven of the respondents rated their quality of life as bad or very bad. 11% of respondents could not determine the level of quality of their lives. The respondents gave similar satisfaction to their health condition. As many as 74% of respondents declare that they are satisfied or very happy with their health. A quarter of the respondents could not determine whether they were satisfied or not about their health. Conclusion : In allergy to hymenoptera insects, a significant impact of the disease on the emotional, professional, social and implemented sphere is observed. The previous experience of anaphylaxis symptoms plays a significant role here, but more importantly anxiety associated with their reoccurrence, which is usually the cause of a deterioration in comfort of life, a sense of security risk. That is why proper education conducted simultaneously with patients' immunotherapy is so important. This has a significant impact on the quality of life of patients allergic and immunotherapy to Hymenoptera venoms.References
Panessar SS., Javad S. , de Silva D. et al. The epidemiology of anaphylaxis in Europe: a systematic review . Allergy 2013; 68: 1353-1361.
Błażowski Ł. Et al .: Anaphylaxis . Special situations. Polish Allergology - Polish Journal of Allergology Nov 2014; 1 (1); 1.
Nittner-Marszalska M. (ed.): Hymenoptera venom allergy . Allergology in practice . Oficyna Wydawnicza Mediton , Łódź 2003; p. 59.
Panessar SS., Javad S. , de Silva D. I et al .: The epidemiology of anaphylaxis in Europe: a systematic review . Allergy 2013; 68: 1353-1361.
ECAP. Epidemiology of Allergic Diseases in Poland (www.ecap.pl)
Kempiński K., Niedoszytko M .: Efficacy of immunotherapy in allergy to Hymenoptera venom. Allergy Asthma Immunology 2011, 16 (3): 125.
Nittner-Marszalska M .: Who we disqualify and who we qualify for immunotherapy ... Allergy Asthma Immunology 2011, 16 (2): 71 .
Szymański W., Złotnik I., Kucharewicz I., Bodzenta-Łukaszyk A .: Efficacy of specific immunotherapy in patients with Hymenoptera venom allergy - evaluation based on in vivo and in vitro methods . Allergy Asthma Immunology, 2002.7 (4), 216.
Kempiński K., Niedoszytko M .: Efficacy of immunotherapy in allergy to hymenoptera venom. Allergy Asthma Immunology 2011, 16 (3): 124.
Świebocka E., Siergiejko Z .: Provocative test with a live insect - own experience. Allergy, 2012, 1:31.
VIT - immunotherapy for hymenoptera venom ( Venom immunotherapy )
Hymenoptera venom allergy http://www.alrgosan.pl/index.php/artykuly-o-alergiach/5
Jutel M. Insect venom allergies . (in) Internal diseases . Szczeklik A. (ed.). Praktyczna Medical Publishing, Cracow 2011.
Nittner-Marszalska M. (ed.): Hymenoptera venom allergy . Allergology in practice. Oficyna Wydawnicza Mediton , Łódź 2003; pp. 23-24.
Rapiejko P., Lipiec A .: Hymenoptera venom allergens. Allergy profile . Practitioners' Quarterly of Physicians 2009, Vol.2, No. 3, p. 17.
Gawlik R .: Hymenoptera venom and its allergens. (w) Hymenoptera venom allergy . Allergology in practice. Nittner-Marszalska M. (ed.) Mediton Publishing House , Łódź 2003.
Cichocka-Jarosz E .: Anaphylaxis for insect venom . Allergy Asthma Immunology 2014, 19 (1), 11.
Panessar SS., Javad S. , de Silva D. et al. The epidemiology of anaphylaxis in Europe: a systematic review . Allergy 2013; 68: 1353-1361.
Jennings A., Duggan E., Perry U. , Hourihane JO .: Epidemiology of allergic reactions to hymenoptera stings in Irish school children . Pediatric allergy Immunol . 2010; 21: 1166-70.
Worm M .: Epidemiology of anaphylaxis . Hautarzt . 2013; 64: 88.
Worm M .: Epidemiology of anaphylaxis . Hautarzt . 2013; 64: 92.
Bilo BM et al . Diagnosis of Hymenoptera venom allergy . EAACI Position Paper. Allergy 2009; 60: 1330-49.
Nittner-Marszalska M .: Immunotherapy in adults and mature patients - clinical aspects , Advances in Dermatology and Allergology 2009; XXVI, 5: 334.
Cichocka-Jarosz E .: Hymenoptera venom allergy in humans , Folia medica Cracoviensia , Vol. LII, 3-4, 2012: 43 PL ISSN 0015-5616.
Przybilla B .: Immunotherapy with Hymenoptera venom , Contemporary Allergology 2 (16); 53. Ibid, p. 54.
Matysiak J., Kokot Z., Matysiak J .: Bee venom allergy in beekeepers , Allergy Asthma Immunology 2017, 22 (1): 5-11.
Oude Elberink JN , De Monchy JG: " Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom . " The Journal of Allergy and Clinical Immunology [01 Jul 2002, 110 (1): 178].
Mikulski D., Smorawska - Sabanty E., Kowalski M .: " Quality of life of patients with Hymenoptera venom allergy refusing treatment by specific immunotherapy " Allergy Astma Immunologia 2016, 21 (2): 133.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 210
Number of citations: 0